Winning the HIV/AIDS Battle

Winning the HIV/AIDS Battle

Twenty-five years after UBC began working in the field of HIV/AIDS research, its impact has been felt worldwide through groundbreaking treatment and prevention practices. UBC researchers have played a key role in reducing the mortality rate of this disease since the early 1990s, putting Vancouver on the map as the birthplace of modern HIV/AIDS therapy.

A major discovery in the mid-1990s, made possible due to provincial and federal research funding and a committed team of researchers, resulted in the development of the highly effective HAART treatment (Highly Active Antiretroviral Therapy), announced in 1996 at the 11th World AIDS Conference in Vancouver. By 1999, this treatment had resulted in an 85 percent reduction in the mortality rate of AIDS patients and by 2010, the rate of new cases in BC had dropped to pre-1985 levels. HAART is based on the concept of treatment as prevention, which was acknowledged in 2011 as a major medical breakthrough.

But the work hasn’t ended there. With more than 50 researchers, nine faculties, three tier-one Canada Research Chairs and more than 250 graduate students working to find global solutions, UBC continues to play a major role in HIV/AIDS research.

Last year, researchers received $15 million in funding to continue the fight against the HIV/AIDS virus around the world. In South Africa, for example, Dr. David Speert, Sauder Family Professor in the Faculty of Medicine, is exploring at the results of exposure to HIV in the womb on children’s immune systems. And Dr. Richard Lester, Clinical Assistant Professor in the Faculty of Medicine, who has implemented treatment programs in Kenya using cellphones as a primary motivation tool, received a $100,000 Rising Star grant for his work from Grand Challenges Canada. Those are just two examples among dozens of projects and partnerships in which UBC researchers are involved. And if the last 25 years are any indication, their continued work will undoubtedly continue to change the face of HIV/AIDS around the world.

 

Related Content

Research Impact in HIV/AIDS

With more than 50 researchers, nine faculties, three tier-one Canada Research Chairs and more than 250 graduate students working to find global solutions, UBC plays a major role in HIV/AIDS research.

Associated Campus

Vancouver Campus

Associated Commitment

Research Excellence

Twitter

Thank you @UBC’s Dr. Julie van Schalkwyk for teaching the next generation of health professionals! @ubcOBGYN… https://t.co/CXmqnMwxqv
about 16 hours ago.
RT @thandifletcher: This is such important research. Congrats to Elaine Kingwell and Helen Tremlett on their latest published study! #Multi…
about 17 hours ago.
RT @Canada: #DYK that UBC, BC Cancer the Vancouver Coastal Health Research Institute have made huge strides in cancer research with the dev…
about 20 hours ago.
Significant #UBC study suggests that common treatment for multiple sclerosis may prolong life:… https://t.co/s5D1El9AXP
about 21 hours ago.
RT @krebs_claudia: Thank you @UBCMeds for a wonderful evening at Med Ball. And thank you for the MUS teaching award - it was great to sha…
about 22 hours ago.
Congratulations to Jerilynn Prior who was awarded @msfhr’s Aubrey J. Tingle Prize https://t.co/oQws62YCM0… https://t.co/CGWLHbd4gc
3 days ago.
RT @PHSAofBC: Prioritizing women's health: Oak Tree at @BCWomensHosp remains the only clinic of its kind in Canada and Dr. Deborah Money co…
3 days ago.
RT @UBC: Researchers in @ubcengineering and @UBCmedicine are developing a low-cost ‘cancer probe’ could spot deadly melanoma early. https:/…
3 days ago.
RT @ubcnews: #UBC dermatologist Dr. Monica Li on the use of niacinamide on your skin, and its benefits - https://t.co/yv6KKDuLJL via @CBCNe…
3 days ago.
RT @ubcnews: Op-ed: Cancer pain can be eased by palliative radiation therapy, writes @UBCmedicine's @jpil in @ConversationCA - https://t.co…
3 days ago.

Leave a Reply